Naar homepage     
Chronische Cerebro-Spinale Veneuze Insufficiëntie
Aanmelden op het CCSVI.nl forum
Lees Voor (ReadSpeaker)    A-   A+
Over CCSVI.nl | Zoeken | Contact | Forum
PayPal, de veilige en complete manier van online betalen.

iDeal
CCSVI.nl is onderdeel van de
Franz Schelling Stichting
meer informatie
  
Thursday, May 25, 2017 11:50 PM | CCSVI in Multiple Sclerosis Volg link
Sadly, this news is not a surprise. Monoclonal antibody therapies (like Ocrevus and Tysabri) leave the brain vulnerable to serious infections like the JC virus and PML. Here's more from my blog. http://ccsviinms.blogspot.com/2016/05/ocrelizumab-and-wrapping-up-ms.html
PML Reported in Patient Receiving Ocrelizumab
But the case could be attributable to 'carryover' from the patient's previous treatment with natalizumab, the company said.